Castellum, INC Form 4 insider transactions

Andrew Merriman, Chief Operating Officer of Castellum, Inc., purchased 1,202 shares of common stock through the company's Employee Stock Purchase Plan.

Tammy L. Martin, General Counsel and Secretary of Castellum, Inc., purchased 1,202 shares of common stock under the company's Employee Stock Purchase Plan.

Glen R. Ives, President and CEO of Castellum, Inc., reported transactions involving the purchase of common stock and the grant of stock options.

Castellum, Inc.'s General Counsel and Secretary, Tammy L. Martin, acquired 1,329 shares of common stock through the company's employee stock purchase plan.

Castellum, Inc. Director Charles Thomas McMillen reported the sale of 30,000 common stock shares at $0.7043 each.

Castellum, Inc. President and CEO, Glen R. Ives, acquired 2,000 shares of common stock at $0.6157 per share, increasing his beneficial ownership.

Castellum, Inc.'s Chief Operating Officer, Andrew Merriman, purchased 2,000 shares of common stock, increasing his direct beneficial ownership.

Castellum, Inc.'s President and CEO, Glen R. Ives, acquired 10,000 shares of common stock, signaling strong insider confidence.

A director and 10% owner of Castellum, Inc. sold 55,000 shares of common stock for $0.8018 per share.

Castellum, Inc.'s Chief Operating Officer, Andrew Merriman, purchased 3,000 shares of common stock, increasing his beneficial ownership.

Castellum, Inc. General Counsel Jay O. Wright reported the sale of 30,000 shares of common stock at $1.05 per share, executed under a Rule 10b5-1 plan.

Castellum, Inc. Director and EVP Jay O. Wright reported the sale of 18,000 shares of common stock over two days in December 2025.

Jay O. Wright, a Director and EVP at Castellum, Inc., sold 188,000 shares of common stock totaling approximately $224,108 over three days.

Castellum, Inc. Director and EVP Jay O. Wright reported selling 53,000 shares of common stock for approximately $55,740 through pre-arranged trading plans.

Jay O. Wright sold 100,000 CTM shares at about $1.15–$1.156 and continues to hold 7.42 million shares directly.

Castellum, Inc. Director and EVP Jay O. Wright sold 220,000 shares of common stock for a total of $257,200 in two transactions.

Castellum, Inc.'s Chief Financial Officer, David T. Bell, was granted 225,000 stock options with an exercise price of $1.19, vesting over twenty months.

Castellum, Inc. Chief Operating Officer Andrew Merriman was granted 275,000 stock options with an exercise price of $1.19, vesting over twenty months.

Castellum, Inc. director Charles Thomas McMillen received 100,000 stock options as compensation, vesting over 20 months.

Castellum, Inc. Director Bernard S. Champoux received 100,000 stock options as compensation for his board service, exercisable at $1.19 per share.

Castellum, Inc. Director Mark S. Alarie received a grant of 100,000 stock options with an exercise price of $1.19 as compensation for his board service.

Castellum, Inc. CEO Glen R. Ives received a grant of 500,000 stock options with an exercise price of $1.19, vesting over twenty months.

Castellum, Inc. director John Francis Campbell received 100,000 stock options as compensation, exercisable at $1.19 per share.

Jay O. Wright, a Director, 10% Owner, and EVP of Strategy at Castellum, Inc., filed a Form 4 disclosing planned sales of 100,000 shares of common stock totaling approximately $110,500.

A Castellum, Inc. executive and 10% owner sold 233,000 shares of common stock for approximately $260,960 in early September 2025.

Castellum, Inc. Director and Officer Jay O. Wright reported multiple sales of common stock totaling 446,700 shares in early September 2025 under a pre-arranged 10b5-1 plan.

Mark C. Fuller, a former director and affiliate of Castellum, Inc., reported a pre-planned sale of 500,000 common shares at $1.12 per share, effective September 3, 2025.

A Castellum, Inc. director and executive, Jay O. Wright, reported the sale of 64,000 shares of common stock over two days in late August 2025.

Castellum, Inc. Director and EVP Jay O. Wright filed a Form 4 indicating planned sales of 85,000 shares of common stock in August 2025.

Castellum, Inc. Director Charles Thomas McMillen exercised 125,000 stock options, acquiring common stock and increasing his direct beneficial ownership.